iPLATO Enrolls 40 GP Practices onto its "Friends & Family Test" Service in Just Three Weeks

iPLATO iPLATO, the leader in mHealth and Analytics, announced today that it has enrolled 40 GP practices in its 'beta' service for Friends & Family Testing (FFT) between mid-August and the first week of September. New rules mean that GP practices in England must start capturing patient feedback on their performance, in a similar scheme to that used by Hospitals.

The high response rate to the ‘beta’ trial shows that GP's are interested in a simple, cost effective plug-and-play solution that ensures they comply with the new regulations prior to the December 1, 2014 deadline. The FFT service from iPLATO meets NHS reporting requirements, takes 10 minutes to set up, and requires no knowledge, technology or training from the practice all for fully inclusive, capped cost.

"The tight deadline for putting in place the Friends & Family Testing is clearly a challenge for our GP practice partners" says Tobias Alpsten, CEO of iPLATO. "Although David Cameron stated the intention of systematically capturing patient feedback through FFT across the NHS back in May 2012 this requirement only reached our Primary Care partners this year."

With iPLATO already covering 7,000,000 patients in the UK, the new service uses their existing secure, national communication infrastructure to quickly help practices meet this new statutory requirement.

The company is encouraging practices in advance of the deadline to enrol in the free FFT trial by e-mailing This email address is being protected from spambots. You need JavaScript enabled to view it..

Related news articles:

About iPLATO
iPLATO Healthcare is British innovation company dedicated to mHealth and Analytics since 2006.

iPLATO's evidence based mobile health solutions have proven to improve patient access to healthcare, to enable powerful health promotion targeted at people at risk and to support people with long term conditions.

Serving millions of patients and thousands of healthcare professionals every day iPLATO has emerged as the leader in mobile health. Across this network the company is running campaigns to promote smoking cessation, weight loss, childhood immunisation and pandemic awareness as well as mobile disease management services for people with diabetes, hypertension, epilepsy and HIV.

iPLATO Healthcare's mission is to, in partnership with clinicians, help healthcare commissioners transform patient care through cloud based mHealth and Analytics.

Most Popular Now

Most Advanced Artificial Touch for Brain…

For the first time ever, a complex sense of touch for individuals living with spinal cord injuries is a step closer to reality. A new study published in Science, paves...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

New AI Tool Uses Routine Blood Tests to …

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of...

Using AI to Uncover Hospital Patients�…

Across the United States, no hospital is the same. Equipment, staffing, technical capabilities, and patient populations can all differ. So, while the profiles developed for people with common conditions may...

New Method Tracks the 'Learning Cur…

Introducing Annotatability - a powerful new framework to address a major challenge in biological research by examining how artificial neural networks learn to label genomic data. Genomic datasets often contain...

Picking the Right Doctor? AI could Help

Years ago, as she sat in waiting rooms, Maytal Saar-Tsechansky began to wonder how people chose a good doctor when they had no way of knowing a doctor's track record...

From Text to Structured Information Secu…

Artificial intelligence (AI) and above all large language models (LLMs), which also form the basis for ChatGPT, are increasingly in demand in hospitals. However, patient data must always be protected...

AI Innovation Unlocks Non-Surgical Way t…

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery. The proof-of-concept study, co-led...

Deep Learning Model Helps Detect Lung Tu…

A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA)...

New Study Reveals AI's Transformati…

Intensive care units (ICUs) face mounting pressure to effectively manage resources while delivering optimal patient care. Groundbreaking research published in the INFORMS journal Information Systems Research highlights how a novel...

One of the Largest Global Surveys of Soc…

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch...